COVID‐19 metabolism: Mechanisms and therapeutic targets

Author:

Wang Tianshi1,Cao Ying2,Zhang Haiyan3,Wang Zihao456,Man Cheuk Him7,Yang Yunfan8,Chen Lingchao9,Xu Shuangnian10,Yan Xiaojing11,Zheng Quan12,Wang Yi‐Ping456

Affiliation:

1. Shanghai Key Laboratory for Tumor Microenvironment and Inflammation Department of Biochemistry and Molecular Cell Biology Shanghai Jiao Tong University School of Medicine Shanghai China

2. State Key Laboratory of Oncogenes and Related Genes Shanghai Cancer Institute Renji Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

3. Bai Jia Obstetrics and Gynecology Hospital Shanghai China

4. Fudan University Shanghai Cancer Center Key Laboratory of Breast Cancer in Shanghai Shanghai Key Laboratory of Radiation Oncology Cancer Institute and The Shanghai Key Laboratory of Medical Epigenetics Institutes of Biomedical Sciences Shanghai Medical College Fudan University Shanghai China

5. Department of Oncology Shanghai Medical College Fudan University Shanghai China

6. The International Co‐laboratory of Medical Epigenetics and Metabolism Ministry of Science and Technology Shanghai China

7. Division of Hematology Department of Medicine University of Hong Kong Pokfulam Hong Kong, China

8. Department of Cell Biology School of Basic Medical Sciences Cheeloo College of Medicine Shandong University Jinan China

9. Department of Neurosurgery Huashan Hospital Shanghai Medical College Fudan University National Center for Neurological Disorders Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration Neurosurgical Institute of Fudan University Shanghai Clinical Medical Center of Neurosurgery Shanghai China

10. Department of Hematology Southwest Hospital Army Medical University Chongqing China

11. Department of Hematology The First Affiliated Hospital of China Medical University Shenyang China

12. Center for Single‐Cell Omics School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shanghai

Shanghai Rising-Star Program

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3